This trial will study the efficacy of MBSR + psilocybin psychotherapy for frontline healthcare workers battling depression & burnout from the pandemic.
1 Primary · 7 Secondary · Reporting Duration: Study enrollment to 2 weeks and 6 months post intervention
Awards & Highlights
2 Treatment Groups
Mindfulness-Based Stress Reduction (MBSR)
1 of 2
Mindfulness-Based Stress Reduction (MBSR) + Psilocybin-Assisted Psychotherapy (P...
1 of 2
24 Total Participants · 2 Treatment Groups
Primary Treatment: Mindfulness-Based Stress Reduction (MBSR) + Psilocybin-Assisted Psychotherapy (PAP) · No Placebo Group · Phase < 1
Who is running the clinical trial?
Age 18+ · All Participants · 18 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
What site did they apply to?
|Huntsman Mental Health Institute||100.0%|
What portion of applicants met pre-screening criteria?
|Did not meet criteria||100.0%|
Frequently Asked Questions
Can individuals currently apply to participate in this research?
"As per clinicaltrials.gov, this investigation is still enrolling patients and remains open to applications since its debut on February 1st 2023 and recent amendment on April 26th 2023." - Anonymous Online Contributor
How many individuals are currently involved in this research endeavor?
"Affirmative. Clinicaltrials.gov confirms that, since its inception on 2nd January 2023 and most recent update on 26th April 2023, this medical trial is actively seeking 24 volunteers from a single site." - Anonymous Online Contributor